Clozapine-induced leukopenia successfully treated with lithium

American Journal of Health-System Pharmacy

Volumn 64, Issue 19, 2007, Pages 2027-2031

  Kutscher, Eric C ^a,b   Robbins, Garry P ^c   Kennedy, W Klugh ^d   Zebb, Kristi ^e   Stanley, Matthew ^f,g   Carnahan, Ryan M ^c  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

^b Avera Health   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d UNIVERSITY OF GEORGIA   (United States)

^e Thrifty White Pharmacy   (United States)

^f UNIVERSITY OF SOUTH DAKOTA   (United States)

^g Avera McKennan Hospital and University Health Center   (United States)

Author keywords

Antimanic agents; Antipsychotic agents; Clozapine; Dosage; Leukopenia; Lithium; Olanzapine; Schizophrenia; Toxicity

Indexed keywords

CLOZAPINE; LITHIUM CARBONATE; OLANZAPINE;

ADULT; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG WITHDRAWAL; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; MAINTENANCE THERAPY; MALE; NEUTROPHIL COUNT; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; SUICIDAL IDEATION; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 34948834235     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060319     Document Type: Article

References (22)

1. Boshes RA, Manschreck TC, Desrosiers J et al. Initiation of clozapine therapy in a patient with preexisting leukopenia: a discussion of the rationale of current treatment options. Ann Clin Psychiatry. 2001; 13:233-7. [Erratum, Ann Clin Psychiatry. 2002; 14:141.]
2. Papetti F, Darcourt G, Giordana JY et al. [Treatment of clozapine-induced agranulocytosis with lithium (two observations).] Encephale. 2004; 30:578-82. In French.
3. Alvir JM, Lieberman JA, Safferman AZ et al. Clozapine-induced agranulocytosis: incidence and risk factors in the United States. N Engl J Med. 1993; 329:162-7.
4. Sporn A, Gogtay N, Ortiz-Aguayo R et al. Clozapine-induced neutropenia in children: management with lithium carbonate. J Child Adolesc Psychopharmacol. 2003; 13:401-4.
5. Blier P, Slater S, Measham T et al. Lithium and clozapine-induced neutropenia/agranulocytosis. Int Clin Psychopharmacol. 1998; 13:137-40.
6. Silverstone PH. Prevention of clozapine-induced neutropenia by pretreatment with lithium. J Clin Psychopharmacol. 1998; 18:86-8. Letter.
7. Adityanjee. Modification of clozapine-induced leukopenia and neutropenia with lithium carbonate. Am J Psychiatry. 1995; 152:648-9.
8. Sperner-Unterweger B, Czeipek I, Gaggl S et al. Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuous treatment with clozapine. Br J Psychiatry. 1998;172:82-4.
9. Conus P, Nanzer N, Baumann P. An alternative to interruption of treatment in recurrent clozapine-induced severe neutropenia. Br J Psychiatry. 2001; 179:180. Letter.
10. Hagg S, Rosenius S, Spigset O. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis. Int Clin Psychopharmacol. 2003; 18:173-4.
11. Stanilla JK, de Leon J, Simpson GM. Clozapine withdrawal resulting in delirium with psychosis: a report of three cases. J Clin Psychiatry. 1997; 58:252-5.
12. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45.
13. Meltzer HY. Suicide in schizophrenia: risk factors and clozapine treatment. J Clin Psychiatry. 1998; 59(suppl 3):15-20.
14. Kane J, Honigfeld G, Singer J et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988; 45:789-96.
15. McEvoy JP, Lieberman JA, Stroup TS et al. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry. 2006; 163:600-10.
16. Davis J, Chen N, Glick I. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry. 2003;60:553-64.
17. Chin-Yee I, Bezchlibnyk-Butler K, Wong L. Use of cytokines for clozapine-induced agranulocytosis. Can J Psychiatry. 1996;41:280-4.
18. Neupogen (filgrastim) package insert. Thousand Oaks, CA: Amgen; 2004.
19. Esposito D, Rouillon F, Limosin F. Continuing clozapine treatment despite neutropenia. Eur J Clin Pharmacol. 2005;60:759-64.
20. Bender S, Linka T, Wolstein J et al. Safety and efficacy of combined clozapinelithium pharmacotherapy. Int J Neuropsychopharmacol. 2004; 7:59-63.
21. Kanaan RA, Kerwin RW. Lithium and clozapine rechallenge: a retrospective case analysis. J Clin Psychiatry. 2006; 67:756-60.
22. Hager ED, Dziambor H, Hohmann D et al. Effects of lithium on thrombopoiesis in patients with low platelet cell counts following chemotherapy or radiotherapy. Biol Trace Elem Res. 2001; 83:139-48.